Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$85.99
+0.59%
Mkt Cap $5.22B
Analyst Ratings
Buy
22
Hold
0
Sell
0
Price Target (54 analysts)
$140.20
Range $123.00 – $165.00
Implied Upside
+63.0%
Consensus $140.20 vs current $85.99
NASDAQ·Healthcare·Biotechnology
$85.99
+0.59%
Mkt Cap $5.22B
Buy
22
Hold
0
Sell
0
Price Target (54 analysts)
$140.20
Range $123.00 – $165.00
+63.0%
Consensus $140.20 vs current $85.99